{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:41:19Z","timestamp":1789425679855,"version":"build-2803163510"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T00:00:00Z","timestamp":1345075200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2012,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Controversy exists regarding the role of PD1 and its ligand PD-L1 in chronic hepatitis B infection. In some studies, persistent HBV infection has been attributed to high levels of PD-1 and PD-L1 expression on HBV-specific T-cells and antigen-presenting cells (APCs) respectively. Other studies revealed that the up-regulation of PD-1 and PD-L1 during an acute inflammation phase is required to offset increasing positive co-stimulatory signals to avoid severe damage by an over-vigorous immune response.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Fifteen chronic hepatitis B patients, with inflammatory flare episode, were recruited prospectively. Based on serum HBV-DNA, HBsAg load, and ALT values, inflammatory flare episode were divided into initial, climax, decline and regression phase. Blood sample and liver biopsy tissues from each individual were taken in these 4 phases respectively. Circulating and intra-hepatic PD1 and PD-L1 expression levels were monitored throughout the inflammatory flare episode by flow cytometry and immunostaining and these expression levels were related to the HBV-specific T-cell changes, expression of pro-inflammatory cytokines, HBV-DNA replication and HBV antigen load.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>]The levels of PD-1 and PD-L1 expressions were significantly up-regulated in the inflammation ascending phase, initial and climax period and in parallel with HBV-specific colon expansion. It showed increasing the level of serum ALT and decreasing the HBV-DNA loads. As the level of inflammation reduced, the circulating and intra-hepatic PD1 and circulating PD-L1 decreased progressively in concordance with serum ALT, HBV-DNA and HBsAg loads decreased except intra-hepatic PD-1 expression. Intra-hepatic PD-L1 expression did not decrease significantly during the regression phase of inflammation compared to that in prior period. The intra-hepatic PD-L1 expression remained relatively on higher level when serum HBV-DNA load and ALT decreased to approximately normal range.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>The relatively high level of intra-hepatic PD-L1 expression during the inflammatory regression period may contribute to constitute an immunosuppressive microenvironment, which facilitate persistent HBV infection via the inhibition of HBV-specific T cell clonal expansion.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1471-230x-12-109","type":"journal-article","created":{"date-parts":[[2012,8,16]],"date-time":"2012-08-16T04:15:54Z","timestamp":1345090554000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Longitudinal fluctuations in PD1 and PD-L1 expression in association with changes in anti-viral immune response in chronic hepatitis B"],"prefix":"10.1186","volume":"12","author":[{"given":"Zhang","family":"Wenjin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Chuanhui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wan","family":"Yunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaikh Abdul","family":"Lateef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Shusen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,8,16]]},"reference":[{"key":"816_CR1","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1016\/j.molimm.2007.07.038","volume":"45","author":"G Peng","year":"2008","unstructured":"Peng G, Li S, Wu W, et al: PD-1 upregulation is associated with HBV-specific T cell dysfunction in chronic hepatitis B patients. Mol Immunol. 2008, 45: 963-970. 10.1016\/j.molimm.2007.07.038.","journal-title":"Mol Immunol"},{"key":"816_CR2","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1002\/hep.22419","volume":"48","author":"A Evans","year":"2008","unstructured":"Evans A, Riva A, Cooksley H, et al: Programmed Death 1 Expression During Antiviral Treatment of Chronic Hepatitis B: Impact of Hepatitis B e-Antigen Seroconversion. Hepatology. 2008, 48: 759-769. 10.1002\/hep.22419.","journal-title":"Hepatology"},{"key":"816_CR3","doi-asserted-by":"publisher","first-page":"8215","DOI":"10.4049\/jimmunol.181.12.8215","volume":"181","author":"A Rutebemberwa","year":"2008","unstructured":"Rutebemberwa A, Ray SC, Astemborski J, et al: High-Programmed Death-1 Levels on Hepatitis C Virus-Specific T Cells during Acute Infection Are Associated with Viral Persistence and Require Preservation of Cognate Antigen during Chronic Infection1. J Immunol. 2008, 181: 8215-8225.","journal-title":"J Immunol"},{"key":"816_CR4","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1128\/JVI.01177-06","volume":"80","author":"S Urbani","year":"2006","unstructured":"Urbani S, Amadei B, Tola D, et al: PD-1 Expression in Acute Hepatitis C Virus (HCV) Infection Is Associated with HCV-Specific CD8 Exhaustion. J Virol. 2006, 80: 11398-11403. 10.1128\/JVI.01177-06.","journal-title":"J Virol"},{"key":"816_CR5","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1189\/jlb.0307168","volume":"83","author":"H-Y Jeong","year":"2008","unstructured":"Jeong H-Y, Lee Y-J, Seo S-K, et al: Blocking of monocyte-associated B7-H1 (CD274) enhances HCV-specific T cell immunity in chronic hepatitis C infection. J Leukoc Biol. 2008, 83: 755-764.","journal-title":"J Leukoc Biol"},{"key":"816_CR6","doi-asserted-by":"publisher","first-page":"4215","DOI":"10.1128\/JVI.02844-06","volume":"81","author":"B Carolina","year":"2007","unstructured":"Carolina B, Paola F, Caterina V: Characterization of Hepatitis B Virus (HBV)-Specific T-Cell Dysfunction in Chronic HBV Infection. J Virol. 2007, 81: 4215-4225. 10.1128\/JVI.02844-06.","journal-title":"J Virol"},{"key":"816_CR7","doi-asserted-by":"publisher","first-page":"3154","DOI":"10.1128\/JVI.02474-07","volume":"82","author":"K Victoria","year":"2008","unstructured":"Victoria K, Wiesch JSz, Thomas K, et al: High Level of PD-1 Expression on Hepatitis C Virus (HCV)-Specifi CD8+ and CD4+ T Cells during Acute HCV Infection, Irrespective of Clinical Outcome. J Virol. 2008, 82: 3154-3160. 10.1128\/JVI.02474-07.","journal-title":"J Virol"},{"key":"816_CR8","doi-asserted-by":"publisher","first-page":"9249","DOI":"10.1128\/JVI.00409-07","volume":"81","author":"G-M Lucy","year":"2007","unstructured":"Lucy G-M, Brent P, Jared K, et al: Upregulation of PD-1 Expression on Circulating and Intrahepatic Hepatitis C Virus-Specific CD8+ T Cells Associated with Reversible Immune Dysfunction. J Virol. 2007, 81: 9249-9258. 10.1128\/JVI.00409-07.","journal-title":"J Virol"},{"key":"816_CR9","doi-asserted-by":"publisher","first-page":"3637","DOI":"10.4049\/jimmunol.170.7.3637","volume":"170","author":"N Selenko-Gebauer","year":"2003","unstructured":"Selenko-Gebauer N, Majdic O, Szekeres A, et al: B7-H1 (Programmed Death-1 Ligand) on Dendritic Cells Is Involved in the Induction and Maintenance of T Cell Anergy. J Immunol. 2003, 170: 3637-3644.","journal-title":"J Immunol"},{"key":"816_CR10","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1084\/jem.20022235","volume":"198","author":"Y Iwai","year":"2003","unstructured":"Iwai Y, Terawaki S, Ikegawa M, et al: PD-1 Inhibits Antiviral Immunity at the Effector Phase in the Liver. J. Exp. Med. 2003, 198: 39-50. 10.1084\/jem.20022235.","journal-title":"J. Exp. Med"},{"key":"816_CR11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1136\/gut.2006.093906","volume":"56","author":"A Karrar","year":"2007","unstructured":"Karrar A, Broome U, Uzunel M, et al: Human liver sinusoidal endothelial cells induce apoptosis in activated T cells: a role in tolerance induction. Gut. 2007, 56: 243-252. 10.1136\/gut.2006.093906.","journal-title":"Gut"},{"key":"816_CR12","doi-asserted-by":"publisher","first-page":"6634","DOI":"10.4049\/jimmunol.178.10.6634","volume":"178","author":"L Chen","year":"2007","unstructured":"Chen L, Zhang Z, Chen W, et al: B7\u2013H1 up-regulation on myeloid dendritic cells significantly suppresses T cell immune function in patients with chronic hepatitis B. J Immunol. 2007, 178: 6634-6641.","journal-title":"J Immunol"},{"key":"816_CR13","doi-asserted-by":"publisher","first-page":"1312","DOI":"10.1002\/hep.20488","volume":"40","author":"MC Yu","year":"2005","unstructured":"Yu MC, Chen CH, Liang X, et al: Inhibition of T-cell responses by hepatic stellate cells via B7-H1-mediated T-cell apoptosis in mice. Hepatology. 2005, 40: 1312-1321.","journal-title":"Hepatology"},{"issue":"5","key":"816_CR14","doi-asserted-by":"publisher","first-page":"1625","DOI":"10.1002\/hep.23173","volume":"50","author":"R Kassel","year":"2009","unstructured":"Kassel R, Cruise MW, Iezzoni JC, et al: Chronically inflamed livers up-regulate expression of inhibitory B7 family members. Hepatology. 2009, 50 (5): 1625-1637. 10.1002\/hep.23173.","journal-title":"Hepatology"},{"key":"816_CR15","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1146\/annurev.iy.12.040194.005015","volume":"12","author":"M Poly","year":"1994","unstructured":"Poly M: Tolerance, danger, and the extended family. Annu. Rev.lmmunol. 1994, 12: 991-1045. 10.1146\/annurev.iy.12.040194.005015.","journal-title":"Annu. Rev.lmmunol"},{"key":"816_CR16","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.193.1.35","volume":"193","author":"Y By Hiroyuki","year":"2001","unstructured":"By Hiroyuki Y, Kenjiro M, Yanyun Z, et al: Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract\u2013associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001, 193: 35-49. 10.1084\/jem.193.10.F35.","journal-title":"J. Exp. Med"},{"key":"816_CR17","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1084\/jem.193.1.35","volume":"193","author":"Y Hiroyuki","year":"2001","unstructured":"Hiroyuki Y, Kenjiro M, Yanyun Z, et al: Regulation by chemokines of circulating dendritic cell precursors, and the formation of portal tract\u2013associated lymphoid tissue, in a granulomatous liver disease. J. Exp. Med. 2001, 193: 35-49. 10.1084\/jem.193.10.F35.","journal-title":"J. Exp. Med"},{"key":"816_CR18","doi-asserted-by":"publisher","first-page":"1445","DOI":"10.1016\/S0002-9440(10)62570-9","volume":"160","author":"AJ Grant","year":"2002","unstructured":"Grant AJ, Goddard S, Ahmed-Choudhury J, et al: Hepatic expression of secondary lymphoid chemokine (CCL21) promotes the development of portal-associated lymphoid tissue in chronic inflammatory liver disease. Am J Pathol. 2002, 160: 1445-1455. 10.1016\/S0002-9440(10)62570-9.","journal-title":"Am J Pathol"},{"key":"816_CR19","doi-asserted-by":"publisher","first-page":"3581","DOI":"10.4049\/jimmunol.169.7.3581","volume":"169","author":"MM Mazanet","year":"2002","unstructured":"Mazanet MM, Hughes CC, et al: B7\u2013H1 is expressed by human endothelial cells and suppresses T cell cytokine synthesis. J Immunol. 2002, 169: 3581-3588.","journal-title":"J Immunol"},{"key":"816_CR20","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1002\/eji.200324270","volume":"33","author":"N Rodig","year":"2003","unstructured":"Rodig N, Ryan T, Allen J: A., Greenfield, E A, et al.: Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol. 2003, 33: 3117-3126. 10.1002\/eji.200324270.","journal-title":"Eur J Immunol"},{"key":"816_CR21","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.jhep.2006.05.007","volume":"45","author":"M Muhlbauer","year":"2006","unstructured":"Muhlbauer M, M Fleck C, Schutz T, et al: PD-L1 is induced in hepatocytes by viral infection and by interferon-\u03b1 and\u03b3and mediates T cell apoptosis. J Hepatol. 2006, 45: 520-528. 10.1016\/j.jhep.2006.05.007.","journal-title":"J Hepatol"},{"issue":"9","key":"816_CR22","doi-asserted-by":"publisher","first-page":"2111","DOI":"10.1084\/jem.20072076","volume":"205","author":"D Abhishek","year":"2008","unstructured":"Abhishek D, Matthew H, Nathan D, et al: Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med. 2008, 205 (9): 2111-2124. 10.1084\/jem.20072076.","journal-title":"J Exp Med"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-230X-12-109\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-109","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-230X-12-109.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T20:32:31Z","timestamp":1630528351000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/1471-230X-12-109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8,16]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,12]]}},"alternative-id":["816"],"URL":"https:\/\/doi.org\/10.1186\/1471-230x-12-109","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,16]]},"assertion":[{"value":"11 March 2012","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 August 2012","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 August 2012","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"109"}}